Th response to Helicobacter pylori differs between patients with gastric ulcer and duodenal ulcer

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 6, 2005, Pages 641-647

  Itoh, Toshiyuki ^a   Seno, Hiroshi ^a   Kita, Toru ^a   Chiba, Tsutomu ^a   Wakatsuki, Yoshio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Duodenal ulcer; Gastric ulcer; H. pylori; Th balance

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; INTERLEUKIN 4; PEPSINOGEN I; PEPSINOGEN II;

ADULT; ARTICLE; CELL INFILTRATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM ULCER; DYSPEPSIA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; MALE; PLASMA CELL; PRIORITY JOURNAL; STOMACH ULCER; T LYMPHOCYTE; TH1 CELL;

ADULT; COHORT STUDIES; CYTOKINES; DISEASE PROGRESSION; DUODENAL ULCER; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PEPSINOGEN A; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STOMACH ULCER; T-LYMPHOCYTE SUBSETS;

EID: 20444496068     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520510015520     Document Type: Article

References (39)

1. Kawai K, Shirakawa K, Misaki F, Hayashi K, Watanabe Y. Natural history and epidemiologic studies of peptic ulcer disease in Japan. Gastroenterology 1989;96 Suppl 1:581-5.
2. Aoyama N, Kinoshita Y, Fujimoto S, Himeno S, Todo A, Kasuga M, et al. Peptic ulcers after the Hanshin-Awaji earthquake: increased incidence of bleeding gastric ulcers. Am J Gastroenterol 1998;93:311-6.
3. Bonnevie O. The incidence of duodenal ulcer in Copenhagen county. Gastroenterology 1975;10:485-93.
4. Kurata JH, Haile BM. Epidemiology of peptic ulcer disease. Clin Gastroenterol 1984;13:289-307.
5. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
6. McColl KE, El-Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol 1996;Suppl 215: 32-7.
7. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002;50:378-81.
8. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinoma. Natl Rev Cancer 2002;2:28-37.
9. Chiba T. Factors contributing to the development of gastric cancer due to Helicobacter pylori infection. Curr Gastroenterol Rep 2002;4:267-8.
10. Yamamoto S. Stomach cancer incidence in the world. Jpn J Clin Oncol 2001;31:471.
11. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
12. Arents NL, van Zwet AA, Thijs JC, Kooistra-Smid AM, van Slochteren KR, Degener JE, et al. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol 2001;96:2603-8.
13. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, et al. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999;44:336-41.
14. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2002;404:398-402.
15. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japan. J Gastroenterol 2001;36:696-9.
16. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al. Genetic differences in interleukin-1β polymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res 2003;22:47-55.
17. Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, Jung WW, et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 2004;114:465-71.
18. Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N, et al. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 2003;124:1879-90.
19. Genta PM, Hamner HW, Graham DY. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol 1993;24: 577-83.
20. Hatz RA, Meimarakis G, Bayerdorffer E, Stolte M, Kirchner T, Enders G. Characterization of lymphocyte infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 1996;31:222-8.
21. Itoh T, Wakatsuki Y, Yoshida M, Usui T, Matsunaga Y, Kaneko S, et al. The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection. J Gastroenterol 1999;34:560-70.
22. Oberhuber G, Bodingbauer M, Mosberger I, Stolte M, Vogelsang H. High proportion of granzyme B-positive (activated) intraepithelial and lamina propria lymphocytes in lymphocytic gastritis. Am J Surg Pathol 1998;22:450-8.
23. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994;29:425-9.
24. Feldman M, Richardson CT, Lam SK, Samloff IM. Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in occidental and oriental duodenal ulcer patients. Gastroenterology 1988;95:630-5.
25. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998;93:1090-6.
26. Chiba T, Watanabe T, Ito T. Helicobacter pylori infection and acid secretion in patients with duodenal ulcer in Japan. Gut 2001;48:871-2.
27. Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000;46:20-6.
28. Wallace JL, Cucala M, Mugridge K, Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991;261:G559-64.
29. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduced risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002;123:92-105.
30. Bhan AK, Mizoguchi E, Smith RN, Mizoguchi A. Colitis in transgenic and knock-out animals as models of human inflammatory bowel disease. Immunol Rev 1999;169:195-207.
31. Fuss IJ, Neurath M, Boirivant J, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4+ lamina propria lymphokine secretion profiles in inflammatory bowel disease. J Immunol 1996;157:1261-70.
32. Blumberg RS, Strober W. Prospects for research in inflammatory bowel disease. JAMA 2001;285:643-7.
33. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4 but not IFN-gamma gene deficient mice. J Immunol 2000;165:1022-9.
34. Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, Shi HN, et al. Concurrent enteric helminth infection modulates inflammation, gastric immune responses and reduces Helicobacter induced gastric atrophy. Nat Med 2000;6:536-42.
35. Itoh T, Yoshida M, Chiba T, Kita T, Wakatsuki Y. A coordinated cytotoxic effect of IFN-γ and cross-reactive antibodies in the pathogenesis of Helicobacter pylori gastritis. Helicobacter 2003;8:268-78.
36. Sipponen P, Kekki M, Siurala M. The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991;6:244-51.
37. Brooks FP. The pathophysiology of peptic ulcer disease. Dig Dis Sci 1985;30 Suppl 11:15S-29S.
38. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
39. Papadimitriou CS, Ioachim-Velogianni EE, Tsianos EB, Mountsopoulos HM. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virchows Arch A Pathol Anat Histopathol 1988; 413:197-204.